UFC 162: Chris Leben gets TUE for opiod Suboxone

USA TODAY Sports

The Nevada State Athletic Commission granted UFC Middleweight Chris Leben a therapeutic use exemption for a prescription opioid medication for his UFC 162 bout with Andrew Craig.

Nevada State Athletic Commission executive director Keith Kizer confirmed today that the NSAC granted a therapeutic use exemption for Suboxone to Chris Leben for his UFC 162 bout against Andrew Craig. The UFC Middleweight has previously served a year's suspension after testing positive for oxycodone and oxymorphone following UFC 138.

Leben is the first fighter to receive a TUE for a painkiller substitute from the NSAC. Leben also served a suspension in 2008 for the anabolic steroid stanozolol in October 2008. Suboxone is a replacement therapy for people struggling with narcotics addiction. MMA Junkie was the first to report the news.

Leben lost his UFC 162 bout to Andrew Craig by split decision. No other fighters on the card received TUE's.

SBN coverage of UFC 162: Silva vs. Weidman


X
Log In Sign Up

forgot?
Log In Sign Up

Forgot password?

We'll email you a reset link.

If you signed up using a 3rd party account like Facebook or Twitter, please login with it instead.

Forgot password?

Try another email?

Almost done,

Join Bloody Elbow

You must be a member of Bloody Elbow to participate.

We have our own Community Guidelines at Bloody Elbow. You should read them.

Join Bloody Elbow

You must be a member of Bloody Elbow to participate.

We have our own Community Guidelines at Bloody Elbow. You should read them.

Spinner

Authenticating

Great!

Choose an available username to complete sign up.

In order to provide our users with a better overall experience, we ask for more information from Facebook when using it to login so that we can learn more about our audience and provide you with the best possible experience. We do not store specific user data and the sharing of it is not required to login with Facebook.

tracking_pixel_5349_tracker